Global Kinase Inhibitors Market to 2016

This study provides an overview of the current and future characteristics of the global market for kinase inhibitors. The key objective is to present a comprehensive analysis and the future direction of kinase inhibitors to provide an important tool for the usage of these types of enzyme inhibitors. This report explores present and future strategies within the kinase inhibitors market, which includes tyrosine inhibitors, multi-target kinase inhibitors, serine/ threonine inhibitors and monoclonal antibody kinase inhibitors. The direction of the market, its setbacks and the needs of the market are discussed in this report. The classifications, comparisons and usage of these types of enzyme inhibitors are also examined in the report. 

A detailed analysis of the kinase inhibitors industry structure has been conducted. Revenues are broken down by region. Sales figures are estimated for the five-year period from 2011 through 2016. 

Applications for kinase inhibitors are also discussed separately in the report, with emphasis on the usage of the inhibitors in therapeutic categories and various disease sectors. The report also covers significant patents and a summary of patents awarded in each category. 

REPORT HIGHLIGHTS

• The global kinase inhibitors market reached $28.1 billion in 2010 and nearly $29.1 billion in 2011. The market is expected to reach $40.2 billion by 2016, a compound annual growth rate (CAGR) of 6.7%.
• The U.S. market for kinase inhibitors reached $10.8 billion in 2010 and came down to $10.4 billion in 2011. The market is expected to reach $11.6 billion by 2016, a CAGR of 2.2%.
• The European market for kinase inhibitors reached $9.1 billion in 2010 and $9.3 billion in 2011. The market is expected to reach $11.6 billion by 2016, a CAGR of 4.4%.

The scope of this study encompasses kinase inhibitors in pharmaceutical and biotechnology markets. BCC analyzes each market and its applications, regulatory environment, technology, market projections and market share. Technological issues include the latest trends and developments. The emerging market for enzyme inhibitors includes India, China, Japan, South Korea, Taiwan, Canada, Africa, Australia and New Zealand and others countries. 

Buy your copy of this report @ http://www.reportsnreports.com/reports/169521-kinase-inhibitors-global-markets.html

Report Details:

 Published: June 2012 

No. of Pages: 219

Price: Single User License – US$4850              Corporate User License – US$8500

Major points covered in Table of Contents of this report include:

Chapter - 1: INTRODUCTION
STUDY OBJECTIVES 
REASONS FOR DOING THIS STUDY 
INTENDED AUDIENCE 
SCOPE OF THE STUDY 
METHODOLOGY 
INFORMATION SOURCES 
ABOUT THE AUTHOR 
RELATED BCC RESEARCH REPORTS 
BCC ONLINE SERVICES 
DISCLAIMER 

Chapter - 2: SUMMARY
Table Summary: GLOBAL REVENUE OF KINASE INHIBITORS MARKET, THROUGH 2016 
Figure Summary: GLOBAL REVENUE OF KINASE INHIBITORS MARKET, 2009-2016 

Chapter - 3: OVERVIEW

Chapter - 4: REGULATORY ASPECTS

Chapter - 5: NEW DEVELOPMENTS

Chapter - 6: GLOBAL MARKETS

Chapter - 7: MARKETS IN THE UNITED STATES

Chapter - 8: MARKETS IN EUROPE

Chapter - 9: MARKETS IN ASIA

Chapter - 10: EMERGING MARKETS

Chapter - 11: PATENT ANALYSIS

Chapter - 12: CURRENT STATUS

Chapter - 13: COMPANY PROFILES 

Chapter - 14: ABBREVIATIONS

List of Tables

List of Figures

Browse reports related to Biotecnology @ http://www.reportsnreports.com/market-research/biotechnology/